• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SUBMUCOSAL INJECTION AGENT; ORISE GEL (SUBMUCOSAL LIFTING AGENT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SUBMUCOSAL INJECTION AGENT; ORISE GEL (SUBMUCOSAL LIFTING AGENT) Back to Search Results
Model Number M00519200
Device Problem Nonstandard Device (1420)
Patient Problem Insufficient Information (4580)
Event Type  malfunction  
Event Description
Received a recall notice for boston scientific's orise gel gtin: (b)(4), ref: (b)(4).Lot: 29313438.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUBMUCOSAL INJECTION AGENT
Type of Device
ORISE GEL (SUBMUCOSAL LIFTING AGENT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
MDR Report Key16051329
MDR Text Key306346140
Report NumberMW5114007
Device Sequence Number1
Product Code PLL
UDI-Device Identifier08714729974567
UDI-Public(01)08714729974567
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 12/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date04/28/2024
Device Model NumberM00519200
Device Catalogue NumberM00519200
Device Lot Number2931348
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/23/2022
Patient Sequence Number1
-
-